Bone Biologics Corp. BBLG 深 沪
等待开盘 02-05 09:30:00 美东时间
1.59
+0.010
+0.63%
华盛通- 最 高1.64
- 今 开1.64
- 成交量 1.01万股
- 最 低 1.58
- 昨 收 1.58
- 总市值 285.45万
- 52周最高 7.50
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.30
- 委 比 41.52%
- 总股本 179.53万
- 历史最高 10255.68
- 量 比 1.10
- 振 幅 3.80%
- 历史最低 1.386
- 每 手 1
- 风险率 1.54%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Trinity Biotech (NASDAQ:TRIB) stock moved upwards by 54.7% to $1.38 du...
2025-12-24 01:05
Bone Biologics Extends Shelf Life Of rhNELL‑1 To 24 Months, Meeting Forecasts
Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ:BBLG, BBLGW))), a developer of orthobiologic products for spine fusion markets, announces it has received confirmation that the shelf life of its
2025-12-23 21:06
Watching Bone Biologics; Zacks Small-Cap Research Gives Stock $22.25 Price Valuation
https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_11172025_BBLG_Sorensen.pdf
2025-11-18 01:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Bone Biologics (NASDAQ:BBLG) shares increased by 30.4% to $2.7 during ...
2025-09-04 20:08
Bone Biologics CEO Issues Stockholder Letter Highlighting NB1 Clinical Progress, Product Improvements, Year-End Enrollment Goal, Expanded Shelf Life, Interim Trial Update, And 2026 Financial Outlook
One-Year OutlookThe firm expect to achieve a number of value-creating events in the coming year under our cost-efficient business model, including the following:Adding additional hospital sites in Australia and
2025-09-04 19:08
Bone Biologics Q2 EPS $(1.33) Misses $(0.58) Estimate
Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(1.33) per share which missed the analyst consensus estimate of $(0.58) by 129.31 percent. This is a 66.92 percent increase over losses of $(4.02) per share from
2025-08-15 05:50
Why Is Bone Biologics Stock Surging On Friday?
Bone Biologics filed a USPTO patent for NELL-1 and announced a $5 million offering to support trials and expand its bone regeneration patent portfolio.
2025-06-27 22:23
Bone Biologics shares are trading higher after the compnay announced it filed a USPTO patent for rhNELL-1.
Bone Biologics shares are trading higher after the compnay announced it filed a...
2025-06-27 20:16
Market-Moving News for June 27th
NKE: 11% | Nike Q4 Earnings: Revenue Beat, EPS Beat, Headwinds Expected To Moderate Moving Forward, Company Playing 'Sport Offense' BBLG: 188% | Bone Biologics Files USPTO Patent For rhNELL-1 Protein In
2025-06-27 19:22
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Plus Therapeutics (NASDAQ:PSTV) stock increased by 66.2% to $0.31 duri...
2025-06-26 01:06
